Depression, cortisol, and suppressed cell-mediated immunity in metastatic breast cancer

Brain, Behavior, and Immunity

Volumn 23, Issue 8, 2009, Pages 1148-1155

  Sephton, Sandra E ^a,b   Dhabhar, Firdaus S ^c,g   Keuroghlian, Alex S ^c   Giese Davis, Janine ^d   McEwen, Bruce S ^e   Ionan, Alexei C ^f   Spiegel, David ^c,g  

^a UNIVERSITY OF LOUISVILLE   (United States)

^b UNIVERSITY OF LOUISVILLE SCHOOL OF MEDICINE   (United States)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF CALGARY   (Canada)

^e ROCKEFELLER UNIVERSITY   (United States)

^f WAYNE STATE UNIVERSITY   (United States)

^g STANFORD CANCER INSTITUTE   (United States)

Author keywords

Anergy; Cancer; Cell mediated immunity (CMI); Cortisol; Delayed type hypersensitivity; Depression; Hypothalamic pituitary adrenal axis (HPA axis); Immunosuppression; Metastatic breast cancer; Neoplasm

Indexed keywords

ANTIGEN; HYDROCORTISONE;

ADULT; ARTICLE; BREAST CANCER; CANCER SURVIVAL; CANDIDA; CELLULAR IMMUNITY; CONTROLLED STUDY; DEPRESSION; DIPHTHERIA; FEMALE; HUMAN; HYDROCORTISONE RELEASE; MAJOR CLINICAL STUDY; MENTAL STRESS; METASTASIS; PRIORITY JOURNAL; PROTEUS; PSYCHOLOGICAL RATING SCALE; SALIVA ANALYSIS; STREPTOCOCCUS; SYMPTOM; TETANUS; TRICHOPHYTON;

BREAST NEOPLASMS; CIRCADIAN RHYTHM; DEPRESSION; FEMALE; HUMANS; HYDROCORTISONE; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; IMMUNITY, CELLULAR; LINEAR MODELS; MIDDLE AGED; NEOPLASM METASTASIS; PATIENT SELECTION; PITUITARY-ADRENAL SYSTEM; PSYCHIATRIC STATUS RATING SCALES; SALIVA; STRESS, PSYCHOLOGICAL;

EID: 73049092762     PISSN: 08891591     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbi.2009.07.007     Document Type: Article

References (118)

1. Abeer, El-Sayed A., and Ramy H.A. Immunological changes in patients with mania: changes in cell mediated immunity in a sample from Egyptian patients. Egyptian J. Immunol. 13 (2006) 79-85
2. Abercrombie H.C., Giese-Davis J., Sephton S., Epel E.S., Turner-Cobb J.M., and Spiegel D. Flattened cortisol rhythms in metastatic breast cancer patients. Psychoneuroendocrinology 29 (2004) 1082-1092
3. Antoni M.H., Lutgendorf S.K., Cole S.W., Dhabhar F.S., Sephton S.E., McDonald P.G., Stefanek M., and Sood A.K. The influence of bio-behavioural factors on tumour biology: pathways and mechanisms. Nat. Rev. Cancer 6 (2006) 240-248
4. Auphan N., DiDonato J.A., Rosette C., Helmberg A., and Karin M. Immunosuppression by glucocorticoids: inhibition of NF-kappa B activity through induction of I kappa B synthesis. Science 270 (1995) 286-290
5. Baars A., Claessen A.M., van den Eertwegh A.J., Gall H.E., Stam A.G., Meijer S., Giaccone G., Meijer C.J., Scheper R.J., Wagstaff J., Vermorken J.B., and Pinedo H.M. Skin tests predict survival after autologous tumor cell vaccination in metastatic melanoma: experience in 81 patients. Annal. Oncol. 11 8 (2000) 965-970
6. Blatt S.P., Hendrix C.W., Butzin C.A., Freeman T.M., Ward W.W., Hensley R.E., Melcher G.P., Donovan D.J., and Boswell R.N. Delayed-type hypersensitivity skin testing predicts progression to AIDS in HIV-infected patients. Annal. Int. Med. 119 3 (1993) 177-184
7. Beekman A.T., Deeg D.J., Van Limbeek J., Braam A.W., De Vries M.Z., and Van Tilburg W. Criterion validity of the Center for Epidemiologic Studies Depression Scale (CES-D): results from a community-based sample of older subjects in The Netherlands. Psychol. Med. 27 (1997) 231-235
8. Ben-Eliyahu S. The promotion of tumor metastasis by surgery and stress: immunological basis and implications for psychoneuroimmunology. Brain Behav. Immun. 17 Suppl 1 (2003) S27-36
9. Ben-Eliyahu S., Page G.G., Yirmiya R., and Shakhar G. Evidence that stress and surgical interventions promote tumor development by suppressing natural killer cell activity. Int. J. Cancer 80 (1999) 880-888
10. Ben-Eliyahu S., Shakhar G., Page G.G., Stefanski V., and Shakhar K. Suppression of NK cell activity and of resistance to metastasis by stress: a role for adrenal catecholamines and beta-adrenoceptors. Neuroimmunomodulation 8 (2000) 154-164
11. Bergsma J. Illness, the mind, and the body: cancer and immunology: an introduction. Theor. Med. 15 (1994) 337-347
12. Blake-Mortimer J.S., Sephton S.E., Carlson R.W., Stites D., and Spiegel D. Cytotoxic T lymphocyte counts and survival time in women with metastatic breast cancer. Breast J. 10 3 (2004) 195-199
13. Brown E.S., Varghese F.P., and McEwen B.S. Association of depression with medical illness: does cortisol play a role?. Biol. Psychiatry 55 1 (2004) 1-9
14. Burgess C., Cornelius V., Love S., Graham J., Richards M., and Ramirez A. Depression and anxiety in women with early breast cancer: five year observational cohort study. British Medical Journal 330 7493 (2005) 702
15. Burke H.M., Davis M.C., Otte C., and Mohr D.C. Depression and cortisol responses to psychological stress: a meta-analysis. Psychoneuroendocrinology 30 9 (2005) 846-856
16. Caplette-Gingras A., and Savard J. Depression in women with metastatic breast cancer: a review of the literature. Palliat. Suppor. Care 6 4 (2008) 377-387
17. Caracciolo B., and Giaquinto S. Criterion validity of the center for epidemiological studies depression (CES-D) scale in a sample of rehabilitation inpatients. J. Rehabilitaion Med. 34 (2002) 221-225
18. Caras I., Grigorescu A., Stavaru C., Radu D.L., Mogos I., Szegli G., and Salageanu A. Evidence for immune defects in breast and lung cancer patients. Cancer Immunol. Immunother. 53 (2004) 1146-1152
19. Chang A.E., Aruga A., Cameron M.J., Sondak V.K., Normolle D.P., Fox B.A., and Shu S. Adoptive immunotherapy with vaccine-primed lymph node cells secondarily activated with anti-CD3 and interleukin-2. J. Clin. Oncol. 15 (1997) 796-807
20. Chida Y., Hamer M., Wardle J., and Steptoe A. Do stress-related psychosocial factors contribute to cancer incidence and survival?. Nat. Clin. Pract. Oncol. 5 8 (2008) 466-475
21. Clay T.M., Hobeika A.C., Mosca P.J., Lyerly H.K., Morse M.A., et al. Assays for monitoring cellular immune responses to active immunotherapy of cancer. Clin. Cancer Res. 7 5 (2001) 1127-1135
22. Curigliano G., Rescigno M., and Goldhirsch A. Immunology and breast cancer: therapeutic cancer vaccines. Breast (Edinburgh, Scotland) 16 Suppl 2 (2007) S20-S26
23. Czarnecki D., Zalcberg J., Kulinskaya E., and Kay T. Impaired cell-mediated immunity of apparently normal patients who had multiple skin cancers. Cancer 76 (1995) 228-231
24. Czarnecki D., Mar A., and Kulinskaya E. Cell-mediated immunity of patients who have had basal cell carcinomas. Acta Dermato Venereologica 76 (1996) 28-30
25. Disis M.L., Grabstein K.H., Sleath P.R., and Cheever M.A. Generation of immunity to the HER-2/neu oncogenic protein in patients with breast and ovarian cancer using a peptide-based vaccine. Clin. Cancer Res. 5 6 (1999) 1289-1297
26. Dhabhar F.S., and McEwen B.S. Stress-induced enhancement of antigen-specific cell-mediated immunity. J. Immunol. 156 (1996) 2608-2615
27. Dhabhar F.S., and McEwen B.S. Acute stress enhances while chronic stress suppresses immune function in vivo: a potential role for leukocyte trafficking. Brain Behav. Immun. 11 (1997) 286-306
28. Dhabhar F.S., and McEwen B.S. Enhancing versus suppressive effects of stress hormones on skin immune function. Proc. Natl. Acad. Sci. USA 96 (1999) 1059-1064
29. Dhabhar F.S., and McEwen B.S. Bidirectional effects of stress on immune function: possible explanations for salubrious as well as harmful effects. In: Ader R. (Ed). Psychoneuroimmunology IV (2006), Elsevier, San Diego 723-760
30. Dhabhar F.S., Miller A.H., McEwen B.S., and Spencer R.L. Effects of stress on immune cell distribution. Dynamics and hormonal mechanisms. J. Immunol. 154 (1995) 5511-5527
31. Dhabhar F.S., Miller A.H., Stein M., McEwen B.S., and Spencer R.L. Diurnal and acute stress-induced changes in distribution of peripheral blood leukocyte subpopulations. Brain Behav. Immun. 8 (1994) 66-79
32. Dhabhar F.S., Satoskar A.R., Bluethmann H., David J.R., and McEwen B.S. Stress-induced enhancement of skin immune function: a role for IFNg. Proc. Natl. Acad. Sci. 97 (2000) 2846-2851
33. Dhabhar F.S., and Viswanathan K. Short-Term Stress Experienced At The Time Of Immunization Induces A Long-lasting Increase In Immunological Memory. Am. J. Physiol. 289 (2005) R738-744
34. Doering L.V., Martinez-Maza O., Vredevoe D.L., and Cowan M.J. Relation of depression, natural killer cell function, and infections after coronary artery bypass in women. Eur. J. Cardiovasc. Nur. 7 (2008) 52-58
35. Dranoff G. Cytokines in cancer pathogenesis and cancer therapy. Nat. Rev. Cancer 4 (2004) 11-22
36. Deuschle M., Schweiger U., Weber B., Gotthardt U., Korner A., Schmider J., Standhardt H., Lammers C.H., and Heuser I. Diurnal activity and pulsatility of the hypothalamus-pituitary-adrenal system in male depressed patients and healthy controls. J. Clin. Endocrinol. Metab. 82 (1997) 234-238
37. Deuschle M., Weber B., Colla M., Depner M., and Heuser I. Effects of major depression, aging and gender upon calculated diurnal free plasma cortisol concentrations: a re-evaluation study. Stress 2 (1998) 281-287
38. Eilber F., and Morton D. Impaired immunologic reactivity and recurrence following cancer surgery. Cancer 25 (1970) 362-367
39. Emens L.A., Reilly R.T., and Jaffee E.M. Breast cancer vaccines: maximizing cancer treatment by tapping into host immunity. Endocrine Relat. Cancer 12 (2005) 1-17
40. Evans D., Petitto J., Leserman J., Perkins D., Stern R., Folds J., Ozer H., and Golden R. Stress, depression and natural killer cells: potential clinical relevance. Clin. Neuropharmacol. 15 Suppl 1 Pt A (1992) 656A-657A
41. Evans D.L., Folds J.D., Petitto J.M., Golden R.N., Pedersen C.A., Corrigan M., Gilmore J.H., Silva S.G., Quade D., and Ozer H. Circulating natural killer cell phenotypes in men and women with major depression. Relation to cytotoxic activity and severity of depression. Arch. Gen. Psychiatry 49 (1992) 388-395
42. Evans D.L., Leserman J., Pedersen C.A., Golden R.N., Lewis M.H., Folds J.A., and Ozer H. Immune correlates of stress and depression. Psychopharmacol. Bull. 25 (1989) 319-324
43. Fass L., and Herberman R.B. Evaluation of a complement-dependent human cytotoxic antibody reactive with Burkitt's lymphoma biopsy cells. Proc. Soc. Exp. Biol. Med. 133 (1970) 286-289
44. Fife A., Beasley P.J., and Fertig D.L. Psychoneuroimmunology and cancer: historical perspectives and current research. Adv. Neuroimmunol. 6 (1996) 179-190
45. Finn O.J. Cancer Immunology. N. Eng. J. Med. 358 (2008) 2704-2715
46. Fries E., Dettenborn L., and Kirschbaum C. The cortisol awakening response (CAR): facts and future directions. Int. J. Psychophysiol. 72 1 (2009) 67-73
47. Fulton A., Miller F., Weise A., and Wei W.Z. Prospects of controlling breast cancer metastasis by immune intervention. Breast Dis. 26 (2006) 115-127
48. Giese-Davis J., Wilhelm F.H., Conrad A., Abercrombie H.C., Sephton S., Yutsis M., Neri E., Taylor C.B., Kraemer H.C., and Spiegel D. Depression and stress reactivity in metastatic breast cancer. Psychosom. Med. 68 (2006) 675-683
49. Gmunder F.K., Konstantinova I., Cogoli A., Lesnyak A., Bogomolov W., and Grachov A.W. Cellular immunity in cosmonauts during long duration spaceflight on board the orbital MIR station. Aviat. Space Environ. Med. 65 (1994) 419-423
50. Graham J., Ramirez A., Love S.B., Richards M., and Burgess C. Stressful life experiences and risk of relapse of breast cancer: observational cohort study. British Med. J. 324 (2002) 1420-1422
51. Hann D., Winter K., and Jacobsen P. Measurement of depressive symptoms in cancer patients: evaluation of the Center for Epidemiological Studies Depression Scale (CES-D). J. Psychosom. Res. 46 (1999) 437-443
52. Herberman R. Principles of tumor immunology. In: Holleb A.I., Fink D.J., and Murphy F.P. (Eds). Textbook of Clinical Oncology (1991), American Cancer Society, Atlanta, GA 69-79
53. Herbert T.B., and Cohen S. Depression and immunity: a meta-analytic review. Psychol. Bull. 113 (1993) 472-486
54. Hersh E., Whitecar J., and McCredie K. Chemotherapy, immunocompetence, immunosuppression and prognosis in acute leukemia. N. Eng. J. Med. 285 (1971) 1212
55. Hickie I., Hickie C., Bennett B., Wakefield D., Silove D., Mitchell P., and Lloyd A. Biochemical correlates of in vivo cell-mediated immune dysfunction in patients with depression: a preliminary report. Int. J. Immunopharmacol. 17 (1995) 685-690
56. Hickie I., Hickie C., Lloyd A., Silove D., and Wakefield D. Impaired in vivo immune responses in patients with melancholia. B. J. Psychiatry 162 (1993) 651-657
57. Hudemann B., and Seyfarth M. Value of DNFB skin testing in patients with bladder cancer (author's transl). Arch Geschwulstforsch 50 (1980) 173-177
58. Irwin M., Daniels M., Bloom E.T., Smith T.L., and Weiner H. Life events, depressive symptoms, and immune function. Am. J. Psychiatry 144 (1987) 437-441
59. Irwin M., and Gillin J.C. Impaired natural killer cell activity among depressed patients. Psychiatry Res. 20 (1987) 181-182
60. Johnson W.C., Ulrich F., Mequid M.M., Lepak N., Bowe P., Harris P., Alberts L.H., and Nabseth D.C. Role of delayed hypersensitivity in predicting postoperative morbidity and mortality. Am. J. Surgery 137 (1979) 536-542
61. Jones R.C., Kelley M., Gupta R.K., Nizze J.A., Yee R., Leopoldo Z., Qi K., Stern S., and Morton D.L. Immune response to polyvalent melanoma cell vaccine in AJCC stage III melanoma: an immunologic survival model. Annal. Surg. Oncol. 3 (1996) 437-445
62. Kiecolt-Glaser J., and Glaser R. Depression and immune function: central pathways to morbidity and mortality. J. Psychosom. Res. 53 (2002) 873-879
63. Kiecolt-Glaser J.K., and Glaser R. Psychoneuroimmunology and cancer: fact or fiction?. Eur. J. Cancer 35 (1999) 1603-1607
64. Kissane D.W., Grabsch B., Love A., Clarke D.M., Bloch S., and Smith G.C. Psychiatric disorder in women with early stage and advanced breast cancer: a comparative analysis. Aus. N. Z. J. Psychiatry 38 (2004) 320-326
65. Ko B.K., Kawano K., Murray J.L., Disis M.L., Efferson C.L., Kuerer H.M., Peoples G.E., and Ioannides C.G. Clinical studies of vaccines targeting breast cancer. Clin. Cancer Res. 9 (2003) 3222-3234
66. Lamb D., Pilney F., Kelly W.D., and Good R.A. A comparative study of the incidence of anergy in patients with carcinoma, leukemia, hodgkin's disease and other lymphomas. J. Immunol. 89 (1962) 555-558
67. Levy S., Herberman R., Lippman M., and D'Angelo T. Correlation of stress factors with sustained depression of natural killer cell activity and predicted prognosis in patients with breast cancer. J. Clin. Oncol. 5 (1987) 348-353
68. Levy S.M., Herberman R.B., Lippman M., D'Angelo T., and Lee J. Immunological and psychosocial predictors of disease recurrence in patients with early-stage breast cancer. Behav. Med. 17 (1991) 67-75
69. Levy S.M., Herberman R.B., Maluish A.M., Schlien B., and Lippman M. Prognostic risk assessment in primary breast cancer by behavioral and immunological parameters. Health Psychol. 4 (1985) 99-113
70. Licinio J., and Wong M.L. The role of inflammatory mediators in the biology of major depression: central nervous system cytokines modulate the biological substrate of depressive symptoms, regulate stress-responsive systems, and contribute to neurotoxicity and neuroprotection. Mol. Psychiatry 4 (1999) 317-327
71. Lillberg K., Verkasalo P.K., Kaprio J., Teppo L., Helenius H., and Koskenvuo M. Stressful life events and risk of breast cancer in 10,808 women: a cohort study. Am. J. Epidemiol. 157 (2003) 415-423
72. Liyanage U.K., Moore T.T., Joo H.G., Tanaka Y., Herrmann V., Doherty G., Drebin J.A., Strasberg S.M., Eberlein T.J., Goedegebuure P.S., et al. Prevalence of regulatory T cells is increased in peripheral blood and tumor microenvironment of patients with pancreas or breast adenocarcinoma. J. Immunol. 169 (2002) 2756-2761
73. Lopez J.F., Akil H., and Watson S.J. Neural circuits mediating stress. Biol. Psychiatry 46 (1999) 1461-1471
74. Lupien S.J., Nair N.P., Briere S., Maheu F., Tu M.T., Lemay M., McEwen B.S., and Meaney M.J. Increased cortisol levels and impaired cognition in human aging: implication for depression and dementia in later life. Rev. Neurosci. 10 (1999) 117-139
75. Maes M. Cytokines in major depression. Biol. Psychiatry 36 (1994) 498-499
76. Maes M., Bosmans E., and Meltzer H.Y. Immunoendocrine aspects of major depression. Relationships between plasma interleukin-6 and soluble interleukin-2 receptor, prolactin and cortisol. Eur. Arch. Psychiatry Clin. Neurosci. 245 (1995) 172-178
77. Marshall Jr. G.D., and Agarwal S.K. Stress, immune regulation, and immunity: applications for asthma. Allergy Asthma Proc. 21 (2000) 241-246
78. Maunsell E., Brisson J., Mondor M., Verreault R., and Deschcnes L. Stressful life events and survival after breast cancer. Psychosom. Med. 63 (2001) 306-315
79. McGregor B.A., and Antoni M.H. Psychological intervention and health outcomes among women treated for breast cancer: a review of stress pathways and biological mediators. Brain Behav. Immun. 23 2 (2009) 159-166
80. Melichar B., Touskova M., Dvorak J., Jandik P., and Kopecky O. The peripheral blood leukocyte phenotype in patients with breast cancer: effect of doxorubicin/paclitaxel combination chemotherapy. Immunopharmacology and Immunotoxicology 23 (2001) 163-173
81. Nielsen N.R., and Gronbaek M. Stress and breast cancer: a systematic update on the current knowledge. Nature Clinical Practice 3 (2006) 612-620
82. Palesh O., Butler L.D., Koopman C., Giese-Davis J., Carlson R., and Spiegel D. Stress history and breast cancer recurrence. J. Psychosom. Res. 63 3 (2007) 233-239
83. Papatheodorou K., Triantafillidis J.K., Kogevinas M., Manoussakis K., Nicolakis D., and Merikas E. Cutaneous delayed hypersensitivity in patients with colorectal cancer: application of multi-test. Ital. J. Gastroenterol. 26 (1994) 12-15
84. Peled R., Carmil D., Siboni-Samocha O., and Shoham-Vardi I. Breast cancer, psychological distress and life events among young women. BMC Cancer 8 (2008) 245
85. Plotsky P.M., Owens M.J., and Nemeroff C.B. Psychoneuroendocrinology of depression. Hypothalamic-pituitary-adrenal axis. Psychiatric Clin. North Am. 21 (1998) 293-307
86. Pockaj B.A., Basu G.D., Pathangey L.B., Gray R.J., Hernandez J.L., Gendler S.J., and Mukherjee P. Reduced T-cell and dendritic cell function is related to cyclooxygenase-2 overexpression and prostaglandin E2 secretion in patients with breast cancer. Annal. Surg. Oncol. 11 (2004) 328-339
87. Radloff L.S. The CES-D scale: a Self-Report Depression Scale for research in the general population. Appl. Psychol. Meas. 1 (1977) 385-401
88. Raison C.L., and Miller A.H. The neuroimmunology of stress and depression. Semin. Clin. Neuropsychiatry 6 (2001) 277-294
89. Ramirez A.J., Craig T.K., Watson J.P., Fentiman I.S., North W.R., and Rubens R.D. Stress and relapse of breast cancer. Br. Med. J. 298 (1989) 291-293
90. Reiche E.M., Morimoto H.K., and Nunes S.M. Stress and depression-induced immune dysfunction: implications for the development and progression of cancer. Int. Rev. Psychiatry 17 (2005) 515-527
91. Riley V. Mouse mammary tumors: alteration of incidence as apparent function of stress. Science 189 (1975) 465-467
92. Riley V. Psychoneuroendocrine influences on immunocompetence and neoplasia. Science 212 (1981) 1100-1109
93. Rowland J.H., and Massie M. Breast cancer. In: Breitbart J.C.H. (Ed) (1998), Oxford University Press, Psycho-Oncology
94. Rozkova D., Horvath R., Bartunkova J., and Spisek R. Glucocorticoids severely impair differentiation and antigen presenting function of dendritic cells despite upregulation of Toll-like receptors. Clin. Immunol. 120 (2006) 260-271
95. Sabbioni M.E., Siegrist H.P., Bacchi M., Bernhard J., Castiglione M., Thurlimann B., Bonnefoi H., Perey L., Herrmann R., Goldhirsch A., and Hurny C. Association between immunity and prognostic factors in early stage breast cancer patients before adjuvant treatment. Breast Cancer Res. Treat. 59 (2000) 279-287
96. Sato T., Maguire Jr. H.C., Mastrangelo M.J., and Berd D. Human immune response to DNP-modified autologous cells after treatment with a DNP-conjugated melanoma vaccine. Clin. Immunol. Immunopathol. 74 (1995) 35-43
97. Saul A.N., Oberyszyn T.M., Daugherty C., Kusewitt D., Jones S., Jewell S., Malarkey W.B., Lehman A., Lemeshow S., and Dhabhar F.S. Chronic stress and susceptibility to skin cancer. J. Nat. Cancer Insts. 97 (2005) 1760-1767
98. Scheinman R.I., Cogswell P.C., Lofquist A.K., and Baldwin Jr. A.S. Role of transcriptional activation of I kappa B alpha in mediation of immunosuppression by glucocorticoids. Science 270 (1995) 283-286
99. Schiffman K., Rinn K., and Disis M.L. Delayed type hypersensitivity response to recall antigens does not accurately reflect immune competence in advanced stage breast cancer patients. Breast Cancer Res. Treat. 74 1 (2002) 17-23
100. Schroevers M.J., Sanderman R., van Sonderen E., and Ranchor A.V. The evaluation of the Center for Epidemiologic Studies Depression (CES-D) Scale: depressed and positive affect in cancer patients and healthy reference subjects. Qual. Life Res. 9 (2000) 1015-1029
101. Schule J., Bergkvist L., Hakansson L., Gustafsson B., and Hakansson A. Down-regulation of the CD3-zeta chain in sentinel node biopsies from breast cancer patients. Breast Cancer Res. Treat. 74 (2002) 33-40
102. Schwarze J., and Bartmann P. Influence of dexamethasone on lymphocyte proliferation in whole blood cultures of neonates. Biol. Neonate 65 (1994) 295-301
103. Sephton S.E., Kraemer H.C., Stites D.P., Di Miceli S., Weissbecker I., and Spiegel D. Improving methods of assessing natural killer cell cytotoxicity. Int. J. Methods Psychiatric Res. 15 1 (2006) 12-21
104. Sephton S., and Spiegel D. Circadian disruption in cancer: a neuroendocrine-immune pathway from stress to disease?. Brain Behav. Immun. 17 (2003) 321-328
105. Sephton S.E., Sapolsky R.M., Kraemer H.C., and Spiegel D. Diurnal cortisol rhythm as a predictor of breast cancer survival. J. Nat. Cancer Insts. 92 (2000) 994-1000
106. Spiegel D., Butler L.D., Giese-Davis J., Koopman C., Miller E., DiMiceli S., Classen C.C., Fobair P., Carlson R.W., and Kraemer H.C. Effects of supportive-expressive group therapy on survival of patients with metastatic breast cancer: a randomized prospective trial. Cancer 110 (2007) 1130-1138
107. Spiegel D., and Giese-Davis J. Depression and cancer: mechanisms and disease progression. Biol. Psychiatry 54 (2003) 269-282
108. Spiegel D., Giese-Davis J., Taylor C.B., and Kraemer H. Stress sensitivity in metastatic breast cancer: analysis of hypothalamic-pituitary-adrenal axis function. Psychoneuroendocrinology 31 (2006) 1231-1244
109. Taylor C.B., Conrad A., Wilhelm F.W., Neri E., DeLorenzo A., Kramer M.A., et al. Psychophysiological and cortisol responses to psychological stress in depressed and non-depressed older men and women with elevated CVD risk. Psychosom. Med. 68 (2006) 538-546
110. Thaker P.H., Han L.Y., Kamat A.A., Arevalo J.M., Takahashi R., Lu C., Jennings N.B., Armaiz-Pena G., Bankson J.A., Ravoori M., Merritt W.M., Lin Y.G., Mangala L.S., Kim T.J., Coleman R.L., Landen C.N., Li Y., Felix E., Sanguino A.M., Newman R.A., Lloyd M., Gershenson D.M., Kundra V., Lopez-Berestein G., Lutgendorf S.K., Cole S.W., and Sood A.K. Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma. Nat. Med. 12 (2006) 939-944
111. Viswanathan K., Daugherty C., and Dhabhar F.S. Stress as an endogenous adjuvant: augmentation of the immunization phase of cell-mediated immunity. Int. J. Immunol. 17 (2005) 1059-1069
112. Viswanathan K., and Dhabhar F.S. Stress-induced enhancement of leukocyte trafficking into sites of surgery or immune activation. Proc. Natl. Acad. Sci. USA 102 (2005) 5808-5813
113. Whiteside T.L., and Herberman R.B. The role of natural killer cells in immune surveillance of cancer. Curr. Opin. Immunol. 7 (1995) 704-710
114. Wolf A.M., Wolf D., Steurer M., Gastl G., Gunsilius E., and Grubeck-Loebenstein B. Increase of regulatory T cells in the peripheral blood of cancer patients. Clin. Cancer Res. 9 (2003) 606-612
115. Whiteside T.L., Vujanovic N.L., and Herberman R.B. Natural killer cells and tumor therapy. Current Topics in Microbiol. Immunol. 230 (1998) 221-244
116. Yehuda R., Teicher M.H., Trestman R.L., Levengood R.A., and Siever L.J. Cortisol regulation in posttraumatic stress disorder and major depression: a chronobiological analysis. Biol. Psychiatry 40 (1996) 79-88
117. Zitvogel L., Tesniere A., and Kroemer G. Cancer despite immunosurveillance: immunoselection and immunosubversion. Nat. Rev. Immunol. 6 (2006) 715-727
118. Zorrilla E.P., Luborsky L., McKay J.R., Rosenthal R., Houldin A., Tax A., McCorkle R., Seligman D.A., and Schmidt K. The relationship of depression and stressors to immunological assays: a meta-analytic review. Brain Behav. Immun. 15 (2001) 199-226